Acadia Pharmaceuticals | ACAD - Trade Debtors

Stock Price
20.72
Daily Change
0.40 1.97%
Monthly
-13.63%
Yearly
20.61%
Q1 Forecast
19.99

Acadia Pharmaceuticals reported $148.23M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.23M 8.79M Dec/2025
ALKERMES USD 334.02M 21.08M Dec/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Corcept Therapeutics USD 59.79M 9.84M Dec/2025
Cytokinetics USD 1.81M 6.6M Sep/2025
Eisai JPY 249.06B 25B Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Incyte USD 1.02B 128.52M Dec/2025
J&J USD 17.61B 235M Sep/2025
Moderna USD 184M 862M Dec/2025
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Vanda Pharmaceuticals USD 47.1M 4.35M Dec/2024
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025